McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
597.17
+12.79 (2.19%)
Jan 23, 2025, 4:00 PM EST - Market closed
McKesson Employees
McKesson had 51,000 employees as of March 31, 2023. The number of employees decreased by 24,000 or -32.00% compared to the previous year.
Employees
51,000
Change (1Y)
-24,000
Growth (1Y)
-32.00%
Revenue / Employee
$6,474,255
Profits / Employee
$49,725
Market Cap
75.80B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
Mar 31, 2020 | 80,000 | 0 | - |
Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
Mar 31, 2018 | 78,000 | 0 | - |
Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
Mar 31, 2014 | 42,800 | -700 | -1.61% |
Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
Mar 31, 2010 | 32,500 | 0 | - |
Mar 31, 2009 | 32,500 | -400 | -1.22% |
Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
Mar 31, 2005 | 25,200 | 600 | 2.44% |
Mar 31, 2004 | 24,600 | 100 | 0.41% |
Mar 31, 2003 | 24,500 | 500 | 2.08% |
Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
Mar 31, 1998 | 13,700 | 400 | 3.01% |
Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
Mar 31, 1996 | 11,300 | -900 | -7.38% |
Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MCK News
- 9 hours ago - McKesson's Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services - Business Wire
- 16 days ago - McKesson Amplify Empowers State Pharmacy Associations Nationwide with Advocacy Funding - Business Wire
- 23 days ago - McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses - Business Wire
- 24 days ago - McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference - Business Wire
- 6 weeks ago - 12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style - Seeking Alpha
- 7 weeks ago - McKesson Corporation (MCK) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - Jim Cramer lists 10 stocks likely to perform well in December - CNBC
- 2 months ago - McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network - Seeking Alpha